We’re proud to offer patients in the US our FDA-approved, glycine-stabilized 10% IVIG, produced with plasma derived from US donors.
Learn more about it here.
Great Commitment.
We never stop in our pursuit of providing safe and effective therapies for patients in need.
The following areas of research and development are underway.
For more information on our clinical trials, past and present, please visit www.clinicaltrials.gov
Our US team is deeply rooted in the plasma industry and passionate about sharing our expertise.
We’re committed to providing
robust clinical and support services:
-
FOR PATIENTS
- Co-pay assistance program*
- Specifically designed to quickly address worries about out-of-pocket expenses at point of care without treatment delays, card activations, or lengthy approval processes
-
FOR SPECIALTY PHARMACIES
- Medical benefits portal
- Quickly access co-pay assistance for patients with medical benefit coverage, streamline therapy initiation, and ensure uninterrupted treatment
- Reimbursement support
- We understand that benefits verification and prior authorization processes can be complex and time-consuming, so we offer dedicated help to navigate these essential steps effectively
-
FOR HEALTHCARE PROVIDERS
- Clinical support and education for infusion nurses
FOR PHARMACIES, PROVIDERS, AND PAYERS
- Medical Affairs team available for clinical inquiries
- Access to our medical experts in immunology
* Terms, conditions and eligibility criteria apply. See here for details.
